Sarda Proteins Hits Upper Circuit Amidst Unprecedented Buying Interest

Sarda Proteins, a key player in the edible oil industry, has been under close observation due to its recent price movements and trading patterns. On 20 Nov 2025, the stock opened at Rs 63.06, marking a new 52-week low, and immediately touched this intraday low without any price fluctuation thereafter. The stock’s performance today contrasts sharply with the broader market, as the Sensex recorded a gain of 0.52%, while Sarda Proteins declined by 4.47%. Despite this, the stock’s order book reveals a striking absence of sellers, with only buy orders queued up, resulting in the upper circuit being triggered.

Over the past week, Sarda Proteins has shown a price movement of -17.14%, while the Sensex has advanced by 1.37%. The one-month performance stands flat at 0.00%, compared to the Sensex’s 1.50% gain. More notably, the three-month and one-year performances reflect significant declines of -54.12% and -41.53% respectively, against Sensex gains of 4.61% and 10.38%. Year-to-date, the stock remains unchanged, whereas the Sensex has appreciated by 9.59%. The longer-term view over three years shows a steep decline of -71.50%, contrasting with the Sensex’s 38.87% rise. However, over five years, Sarda Proteins has recorded a substantial increase of 530.60%, outperforming the Sensex’s 95.14% growth during the same period.

The stock’s technical indicators present a mixed picture. While the current price is above the 200-day moving average, it remains below the 5-day, 20-day, 50-day, and 100-day moving averages. This suggests that despite recent downward pressure, the longer-term trend may still hold some support. The stock’s erratic trading pattern is also notable, having not traded on one day out of the last 20, indicating periods of low liquidity or market interest.

Today’s trading session was marked by an open gap down of 4.47%, with the stock opening directly at the lower circuit price of Rs 63.06 and maintaining that level throughout the day. The absence of sellers has created a scenario where the stock is unable to move below this price, resulting in the upper circuit being hit. This phenomenon is unusual and highlights the extraordinary buying interest in Sarda Proteins, despite its recent underperformance relative to the sector and broader market.

Such a scenario often points to a potential multi-day upper circuit, where the stock remains locked at the upper price band due to persistent demand and lack of supply. Investors and traders should monitor the order book closely in the coming sessions to assess whether this buying momentum sustains or if sellers eventually emerge to balance the market.

From an industry perspective, Sarda Proteins operates within the edible oil sector, which has experienced varied performance in recent months. While the sector has generally shown resilience, individual stocks like Sarda Proteins have faced challenges reflected in their price volatility and trading patterns. The current upper circuit event may indicate a shift in market sentiment or speculative interest, warranting careful analysis by investors.

Market capitalisation metrics place Sarda Proteins in a modest category, with a market cap grade of 3, suggesting it is a small-cap stock with potential for volatility and rapid price movements. This classification often attracts traders looking for high-risk, high-reward opportunities, which may explain the intense buying interest despite recent price declines.

In summary, Sarda Proteins’ trading activity on 20 Nov 2025 is characterised by an extraordinary imbalance between buyers and sellers, culminating in an upper circuit lock. The stock’s recent performance shows significant declines over multiple time frames, contrasting with broader market gains. However, the current buying pressure and absence of sellers could signal a potential reversal or a speculative rally in the near term. Investors should weigh these factors carefully, considering both the risks and opportunities presented by this unusual market behaviour.

Monitoring the stock’s price action, volume, and order book dynamics in the coming days will be crucial to understanding whether this upper circuit scenario evolves into a sustained trend or a short-lived anomaly. Given the stock’s history of erratic trading and significant price swings, a cautious approach is advisable.

Overall, Sarda Proteins remains a stock of interest within the edible oil sector, with its current market activity highlighting the complexities and nuances of small-cap trading in India’s equity markets.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →